Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Endothelial cells can function as cardiac stem cells to produce new heart muscle tissue

Endothelial cells residing in the coronary arteries can function as cardiac stem cells to produce new heart muscle tissue, Vanderbilt University investigators have discovered.

21 Aug 2014

Royal Philips receives 510(k) clearance from FDA for TAVI treatments

Royal Philips (NYSE: PHG AEX: PHIA) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its precision planning application for Transcatheter Aortic-Valve Implantation (TAVI) treatments.

From Philips Healthcare 21 Aug 2014

New gene therapy protects mice from life-threatening heart condition

A new gene therapy developed by researchers at the University of Missouri School of Medicine has been shown to protect mice from a life-threatening heart condition caused by muscular dystrophy.

21 Aug 2014

Study: Patients with 2 or more ED visits in one year account for disproportionate costs

Almost one-third of acute heart failure syndrome patients seen in hospital emergency departments (EDs) in Florida and California during 2010 had ED visits during the following year, findings that suggest a lack of appropriate outpatient care.

21 Aug 2014

Stimulating nerves in ear could improve heart health

Stimulating nerves in your ear could improve the health of your heart, researchers have discovered. A team at the University of Leeds used a standard TENS machine like those designed to relieve labour pains to apply electrical pulses to the tragus, the small raised flap at the front of the ear immediately in front of the ear canal.

20 Aug 2014

First Edition: August 19, 2014

Today's early morning highlights from the major news organizations, including stories about a how a hospital system's data was hacked, involving as many as 4.5 million patients' records.

19 Aug 2014

Implantable heart devices provide same substantial survival benefit, regardless of race

Racial and ethnic minorities who receive implantable devices to treat heart failure derive the same substantial survival benefit from these therapies as white patients, new UCLA-led research shows.

19 Aug 2014

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Decision Resources has expanded its disease-level coverage of the Treatment Algorithms Insight Series, which examines U.S. physicians' prescribing behavior, to provide a quantitative analysis of an agent's penetration into each line of therapy.

19 Aug 2014

Patients who rely on pacemakers and defibrillators run risk of serious health complications

Patients who rely on pacemakers and defibrillators to maintain a normal heart rhythm run the risk of serious health complications if they don't fully understand how the devices work and what to do when they experience an irregular heartbeat.

18 Aug 2014

Study identifies genetic basis for Tibetan adaptation

In an environment where others struggle to survive, Tibetans thrive in the thin air on the Tibetan Plateau, with an average elevation of 14,800 feet.

18 Aug 2014

Diet reduces inflammatory markers in ‘real world’ Type 2 diabetes

Encouraging patients newly diagnosed with Type 2 diabetes to diet or to diet and increase their physical activity reduces markers of inflammation and their cardiovascular risk compared with usual care, real-world study findings show.

15 Aug 2014

Researchers show effects of increased and decreased sodium intake on blood pressure

Two reports from a global collaborative study involving hundreds of investigators from 18 countries published today in the New England Journal of Medicine are shaking up conventional wisdom around salt consumption.

14 Aug 2014

High-dose influenza vaccine 24% more effective in older adults

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications, according to a Vanderbilt-led study published today in the New England Journal of Medicine.

13 Aug 2014

Heart failure is major public health burden in many LMICs

Heart failure is a major public health burden in many low- and middle-income countries (LMICs), with substantial variation in the presentation, causes, management, and outcomes of heart failure across different LMICs, according to a study published in this week's PLOS Medicine.

From CSL Ltd 13 Aug 2014

Experts open new clinic to evaluate heart disease patients for participation in stem cell studies

Regenerative medicine experts at the Cedars-Sinai Heart Institute have opened a new clinic to evaluate heart and vascular disease patients for participation in stem cell medical studies.

13 Aug 2014

Measure Up/Pressure Down campaign improves high blood pressure control in 205,000 patients

Medical groups participating in Measure Up/Pressure Down®, a national hypertension campaign, improved detection or control of high blood pressure for 205,000 Americans living with the disease in the first 12 months of the campaign, the American Medical Group Foundation (AMGF) announced today.

13 Aug 2014

Researchers identify predictors of early rehospitalization among patients with COPD

Researchers at the University of Texas Medical Branch at Galveston have identified predictors of early rehospitalization among patients hospitalized for complications of chronic obstructive pulmonary disease. This study was recently published in the Annals of the American Thoracic Society.

13 Aug 2014

Virtual robotic ultrasound can improve diagnosis of heart failure patients living in rural communities

While in Germany, Partho P. Sengupta, MD, of Icahn School of Medicine at Mount Sinai used a computer to perform a robot-assisted trans-Atlantic ultrasound examination on a person in Boston.

12 Aug 2014

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Sanofi and MannKind Corporation announced today that they have entered into a worldwide exclusive licensing agreement for development and commercialization of Afrezza (insulin human) Inhalation Powder, a new rapid-acting inhaled insulin therapy for adults with type 1 and type 2 diabetes.

11 Aug 2014

Patient with mechanical heart pump receives new gene therapy for heart failure

For the first time in the world, a patient with a mechanical heart pump has received a new gene therapy for heart failure at Harefield Hospital, London.

11 Aug 2014

Heart Failure News and Research

Further Reading

Endothelial cells can function as cardiac stem cells to produce new heart muscle tissue

Royal Philips receives 510(k) clearance from FDA for TAVI treatments

New gene therapy protects mice from life-threatening heart condition

Study: Patients with 2 or more ED visits in one year account for disproportionate costs

Stimulating nerves in ear could improve heart health

First Edition: August 19, 2014

Implantable heart devices provide same substantial survival benefit, regardless of race

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Patients who rely on pacemakers and defibrillators run risk of serious health complications

Study identifies genetic basis for Tibetan adaptation

Diet reduces inflammatory markers in ‘real world’ Type 2 diabetes

Researchers show effects of increased and decreased sodium intake on blood pressure

High-dose influenza vaccine 24% more effective in older adults

Heart failure is major public health burden in many LMICs

Experts open new clinic to evaluate heart disease patients for participation in stem cell studies

Measure Up/Pressure Down campaign improves high blood pressure control in 205,000 patients

Researchers identify predictors of early rehospitalization among patients with COPD

Virtual robotic ultrasound can improve diagnosis of heart failure patients living in rural communities

Sanofi, MannKind sign licensing agreement to develop and commercialize Afrezza Inhalation Powder

Patient with mechanical heart pump receives new gene therapy for heart failure

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News